Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune‐prone mice
Open Access
- 6 July 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (7) , 2227-2239
- https://doi.org/10.1002/art.20359
Abstract
Objective To assess the effects of altered class II major histocompatibility complex (MHCII) expression on circulating autoantibody levels in C57BL/6 (B6) mice congenic for the Sle1 (B6.Sle1 mice) or Nba2 (B6.Nba2 mice) regions. Methods H‐2Ab+/+ (MHCII‐intact), H‐2Ab+/– (MHCII‐intermediate), and H‐2Ab–/– (MHCII‐deficient) littermate B6.Sle1 and B6.Nba2 mice were evaluated for spleen cell phenotype, numbers of splenic Ig‐secreting cells, and serum levels of total IgM, total IgG, IgG antichromatin, IgG antihistone, and IgG anti–double‐stranded DNA (anti‐dsDNA). Results Compared with their MHCII‐intact littermates, MHCII‐deficient B6.Sle1 and B6.Nba2 mice developed markedly decreased circulating levels of IgG autoantibodies, along with decreased circulating levels of total IgG. In sharp contrast, MHCII‐intermediate mice developed increased circulating levels of IgG autoantibodies. This was associated with increased numbers of splenic Ig‐secreting cells and serum levels of total IgG in B6.Sle1 mice, but it occurred without concomitant increases in the numbers of splenic Ig‐secreting cells or serum total IgG levels in B6.Nba2 mice. Conclusion In 2 clinically healthy strains of mice with a genetic proclivity for developing autoantibodies, the effects of class II MHC expression on levels of circulating IgG autoantibodies were found to be complex. In the absence of MHCII expression, circulating IgG autoantibody levels were minimal. With full MHCII expression, circulating IgG autoantibody levels were considerable. With intermediate MHCII expression, circulating IgG autoantibody levels were even greater. These last findings may help explain why heterozygosity at the H‐2 locus is associated with increased autoantibody titers and aggravated disease in certain lupus‐prone mice.Keywords
This publication has 39 references indexed in Scilit:
- Major Histocompatibility Complex Class II–Positive Cortical Epithelium Mediates the Selection of Cd4+25+ Immunoregulatory T CellsThe Journal of Experimental Medicine, 2001
- GENETIC SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUSAnnual Review of Immunology, 1998
- Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.Journal of Clinical Investigation, 1998
- Polygenic control of susceptibility to murine systemic lupus erythematosusImmunity, 1994
- Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.The Journal of Experimental Medicine, 1994
- Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide.The Journal of Experimental Medicine, 1992
- Mice lacking MHC class II moleculesCell, 1991
- The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.The Journal of Experimental Medicine, 1988
- Requirement of H‐2 heterozygosity for autoimmunity in (NZB × NZW)F1 hybrid miceEuropean Journal of Immunology, 1986
- A plaque assay for all cells secreting Ig of a given type or classEuropean Journal of Immunology, 1976